David Banach
MD, MPH, MS
Lecturer in Epidemiology (Microbial Diseases)
Research & Publications
Biography
Research Summary
My current research focuses on the epidemiology, prevention and outcomes of infections with multi-drug resistant bacterial pathogens. The organisms of focus include vancomycin-resistant enterococci (VRE) and multi-drug resistant gram-negative organisms, including those resistant to carbapenem antibiotics.
Specialized Terms; Healthcare-associated infections; Influenza vaccination; Infections in solid organ transplant recipients
Research Interests
Influenza Vaccines; Carbapenems; Infectious Disease Transmission, Professional-to-Patient; Drug Resistance, Multiple, Bacterial; Infectious Disease Medicine; Vancomycin-Resistant Enterococci; Transplant Recipients
Selected Publications
- Active surveillance for carbapenem-resistant Enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile.Banach DB, Francois J, Blash S, Patel G, Jenkins SG, LaBombardi V, Kreiswirth BN, Srinivasan A, Calfee DP. Active surveillance for carbapenem-resistant Enterobacteriaceae using stool specimens submitted for testing for Clostridium difficile. Infection Control And Hospital Epidemiology 2014, 35:82-4.
- Support for mandatory health care worker influenza vaccination among allied health professionals, technical staff, and medical students.Banach DB, Zhang C, Factor SH, Calfee DP. Support for mandatory health care worker influenza vaccination among allied health professionals, technical staff, and medical students. American Journal Of Infection Control 2013, 41:354-6.
- Localized mucosal response to intranasal live attenuated influenza vaccine in adults.Barría MI, Garrido JL, Stein C, Scher E, Ge Y, Engel SM, Kraus TA, Banach D, Moran TM. Localized mucosal response to intranasal live attenuated influenza vaccine in adults. The Journal Of Infectious Diseases 2013, 207:115-24.
- Factors associated with unprotected exposure to 2009 H1N1 influenza A among healthcare workers during the first wave of the pandemic.Banach DB, Bielang R, Calfee DP. Factors associated with unprotected exposure to 2009 H1N1 influenza A among healthcare workers during the first wave of the pandemic. Infection Control And Hospital Epidemiology 2011, 32:293-5.
- Indeterminate QuantiFERON®-TB Gold results in a public health clinic setting.Banach DB, Harris TG. Indeterminate QuantiFERON®-TB Gold results in a public health clinic setting. The International Journal Of Tuberculosis And Lung Disease : The Official Journal Of The International Union Against Tuberculosis And Lung Disease 2011, 15:1623-30.